Kottler Marie-Laure, Hamel Adèle, Malville Elodie, Richard Nicolas
Département Génétique et Reproduction, Unité de génétique moléculaire, CHU de Caen, Avenue Georges Clemenceau, 14033 Caen.
J Soc Biol. 2004;198(1):80-7.
The acquisition of a sexually dimorphic phenotype is a critical event in mammalian development. Hypogonadotropic hypogonadism (HH) results from impaired secretion of GnRH. The patients display with delayed puberty, micropenis and cryptorchidism in the male reflecting gonadotropin insufficiency, and amenorrhea in the female. Kallmann's syndrome (KS) is defined by the association of HH and anosmia or hyposmia (absent smelling sense). Segregation analysis in familial cases has demonstrated diverse inheritance patterns, suggesting the existence of several genes regulating GnRH secretion. The X-linked form of the disease was associated with a genetic defect in the KALI gene located on the Xp22.3 region. KAL1 gene encodes an extracellular matrix glycoprotein anosmin-1, which facilitates neuronal growth and migration. Abnormalities in the migratory processes of the GnRH neurons with the olfactory neurons explain the association of HH with anosmia. Recently, mutations in the FGF recepteur 1 (FGFR1) gene were found in KS with autosomal dominant mode of inheritance. The role of FGFR1 in the function of reproduction requires further investigation. Besides HH with anosmia, there are isolated HH (IHH). No human GnRH mutations have been reported although hypogonadal mice due to a GnRH gene deletion exist. In patients with idiopathic HH and without anosmia an increasing number of GnRH receptor (GnRHR) mutations have been described which represent about 50% of familial cases. The clinical features are highly variable and there is a good relationship between genotype and phenotype. A complete loss of function is associated with the most severe phenotype with resistance to pulsatile GnRH treatment, absence of puberty and cryptorchidism in the male. In contrast, milder loss of function mutations causes incomplete failure of pubertal development. The preponderant role of GnRH in the secretion of LH by the gonadotrophs explains the difference of the phenotype between male and female with partial GnRH resistance. Affected females can have spontaneous telarche and normal breast development while affected males exhibit no pubertal development but normal testis volume, a feature described as "fertile-eunuch". High-dose pulsatile GnRH has been used to induce ovulation. Another gene, called GPR54, responsible for idiopathic HH has been recently described by segregation analysis in two different consanguineous families. The GPR54 gene is an orphan receptor, and its putative ligand is the product of the KISS-1 gene, called metastine. Their roles in the function of reproduction are still unknown.
获得性二态性表型是哺乳动物发育中的一个关键事件。低促性腺激素性性腺功能减退(HH)是由促性腺激素释放激素(GnRH)分泌受损引起的。男性患者表现为青春期延迟、小阴茎和隐睾,反映了促性腺激素不足,女性患者则表现为闭经。卡尔曼综合征(KS)的定义是HH与嗅觉缺失或嗅觉减退(嗅觉丧失)相关。家族性病例的分离分析显示了多种遗传模式,提示存在多个调节GnRH分泌的基因。该疾病的X连锁形式与位于Xp22.3区域的KALI基因的遗传缺陷有关。KAL1基因编码一种细胞外基质糖蛋白anosmin-1,它促进神经元的生长和迁移。GnRH神经元与嗅觉神经元迁移过程中的异常解释了HH与嗅觉缺失的关联。最近,在具有常染色体显性遗传模式的KS中发现了成纤维细胞生长因子受体1(FGFR1)基因突变。FGFR1在生殖功能中的作用需要进一步研究。除了伴有嗅觉缺失的HH外,还有孤立性HH(IHH)。尽管存在由于GnRH基因缺失导致性腺功能减退的小鼠,但尚未报道人类GnRH突变。在特发性HH且无嗅觉缺失的患者中,越来越多的GnRH受体(GnRHR)突变被描述,约占家族性病例的50%。临床特征高度可变,基因型与表型之间存在良好的相关性。功能完全丧失与最严重的表型相关,对脉冲式GnRH治疗有抵抗,男性无青春期发育和隐睾。相比之下,功能丧失较轻的突变导致青春期发育不完全失败。GnRH在促性腺细胞分泌促黄体生成素(LH)中的主要作用解释了部分GnRH抵抗的男性和女性之间表型的差异。受影响的女性可能有自发乳房发育和正常的乳房发育,而受影响的男性则无青春期发育但睾丸体积正常,这一特征被描述为“生育型宦官”。高剂量脉冲式GnRH已被用于诱导排卵。另一个名为GPR54的基因,负责特发性HH,最近在两个不同的近亲家族中通过分离分析被描述。GPR54基因是一种孤儿受体,其推定的配体是KISS-1基因的产物,称为metastine。它们在生殖功能中的作用仍然未知。